The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you know frankly i think the cost of an apob is you know at least in canada and the only reason i know that is because alan schneiderman is at mcgill and you know he's been pounding this for a while i mean we're talking about a three or four dollar test so there is no excuse for any physician to say we're not going to order your fancy apo b because it costs too much i'm going to order the ldl cholesterol i think that excuse has lost all of its water
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so of all the technologies to quantitate atherogenic lipoproteins apob is the most affordable and even you know look labs sometimes change crazy but if you tell a lab you want to pay a cash price it's really pretty cheap